Eugia Pharma receives USFDA approval for Lenalidomide capsules, Health News, ET HealthWorld
), Revlimid Capsules 2.5 mg, 5 mg, 10 mg, 15 mg, 20 mg, and 25 mg of Bristol-Myers Squibb Company, the firm said in a statement.
The product is expected to be launched in October 2023.
"This is the 155th ANDA (including 9 tentative approvals received) out of Eugia Pharma Speciality Group (EPSG) facilities, manufacturing both oral and sterile speciality products," it said.
"The approved product is indicated for the treatment of adult patients with Multiple myeloma, in combination with Dexamethasone."
Hyderabad-headquartered Aurobindo Pharma manufactures a wide range of generic pharmaceuticals, branded speciality pharmaceuticals and active pharmaceutical ingredients globally in over 150 countries.
Follow and connect with us on Twitter, Facebook, Linkedin,
Thursday, March 9, 2023 at 6:05 am